103 related articles for article (PubMed ID: 7595232)
1. CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73.
Airas L; Hellman J; Salmi M; Bono P; Puurunen T; Smith DJ; Jalkanen S
J Exp Med; 1995 Nov; 182(5):1603-8. PubMed ID: 7595232
[TBL] [Abstract][Full Text] [Related]
2. T cell signalling through CD73.
Resta R; Thompson LF
Cell Signal; 1997 Feb; 9(2):131-9. PubMed ID: 9113412
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Purine Metabolism-Potential Target in Multiple Sclerosis.
Laketa D; Lavrnja I
Mol Neurobiol; 2024 Mar; ():. PubMed ID: 38499905
[TBL] [Abstract][Full Text] [Related]
4. Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity.
Santosh Nirmala S; Kayani K; Gliwiński M; Hu Y; Iwaszkiewicz-Grześ D; Piotrowska-Mieczkowska M; Sakowska J; Tomaszewicz M; Marín Morales JM; Lakshmi K; Marek-Trzonkowska NM; Trzonkowski P; Oo YH; Fuchs A
Front Immunol; 2023; 14():1321228. PubMed ID: 38283365
[TBL] [Abstract][Full Text] [Related]
5. Ecto-5'-nucleotidase (CD73): an emerging role as prognostic factor in allergic sensitization.
Morello S; Cicala C
Inflamm Res; 2024 Jan; 73(1):111-115. PubMed ID: 38087076
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the Intricacies of CD73/Adenosine Signaling: The Pulmonary Immune and Stromal Microenvironment in Lung Cancer.
Saigí M; Mesía-Carbonell O; Barbie DA; Guillamat-Prats R
Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067409
[TBL] [Abstract][Full Text] [Related]
7. Appraisal of novel azomethine-thioxoimidazolidinone conjugates as ecto-5'-nucleotidase inhibitors: synthesis and molecular docking studies.
Channar PA; Bano S; Hassan S; Perveen F; Saeed A; Mahesar PA; Khan IA; Iqbal J
RSC Adv; 2022 Jun; 12(27):17596-17606. PubMed ID: 35765454
[TBL] [Abstract][Full Text] [Related]
8. The Multifaceted Actions of CD73 During Development and Suppressive Actions of Regulatory T Cells.
Da M; Chen L; Enk A; Ring S; Mahnke K
Front Immunol; 2022; 13():914799. PubMed ID: 35711418
[TBL] [Abstract][Full Text] [Related]
9. Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy.
Wu HL; Gong Y; Ji P; Xie YF; Jiang YZ; Liu GY
J Hematol Oncol; 2022 Apr; 15(1):45. PubMed ID: 35477416
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte Membrane Enzymes Play the Cell Adhesion Game.
López-Cortés GI; Díaz-Alvarez L; Ortega E
Front Immunol; 2021; 12():742292. PubMed ID: 34887854
[TBL] [Abstract][Full Text] [Related]
11. Targeting Hypoxia-A2A Adenosinergic Immunosuppression of Antitumor T Cells During Cancer Immunotherapy.
Steingold JM; Hatfield SM
Front Immunol; 2020; 11():570041. PubMed ID: 33117358
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Selective Altered Glycosylation and Functional Attenuation of CD73 in Human Hepatocellular Carcinoma.
Alcedo KP; Guerrero A; Basrur V; Fu D; Richardson ML; McLane JS; Tsou CC; Nesvizhskii AI; Welling TH; Lebrilla CB; Otey CA; Kim HJ; Omary MB; Snider NT
Hepatol Commun; 2019 Oct; 3(10):1400-1414. PubMed ID: 31592495
[TBL] [Abstract][Full Text] [Related]
13. Cell type- and tissue-specific functions of ecto-5'-nucleotidase (CD73).
Minor M; Alcedo KP; Battaglia RA; Snider NT
Am J Physiol Cell Physiol; 2019 Dec; 317(6):C1079-C1092. PubMed ID: 31461341
[TBL] [Abstract][Full Text] [Related]
14. Generation and Function of Non-cell-bound CD73 in Inflammation.
Schneider E; Rissiek A; Winzer R; Puig B; Rissiek B; Haag F; Mittrücker HW; Magnus T; Tolosa E
Front Immunol; 2019; 10():1729. PubMed ID: 31404305
[TBL] [Abstract][Full Text] [Related]
15. Neutrophils as sources of dinucleotide polyphosphates and metabolism by epithelial ENPP1 to influence barrier function via adenosine signaling.
Curtis VF; Cartwright IM; Lee JS; Wang RX; Kao DJ; Lanis JM; Burney KM; Welch N; Hall CHT; Goldberg MS; Campbell EL; Colgan SP
Mol Biol Cell; 2018 Nov; 29(22):2687-2699. PubMed ID: 30188771
[TBL] [Abstract][Full Text] [Related]
16. Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E.
Kordaß T; Osen W; Eichmüller SB
Front Immunol; 2018; 9():813. PubMed ID: 29720980
[TBL] [Abstract][Full Text] [Related]
17. Unveiling the Role of Ecto-5'-Nucleotidase/CD73 in Astrocyte Migration by Using Pharmacological Tools.
Adzic M; Nedeljkovic N
Front Pharmacol; 2018; 9():153. PubMed ID: 29545748
[TBL] [Abstract][Full Text] [Related]
18. Selective activation of anti-CD73 mechanisms in control of primary tumors and metastases.
Vijayan D; Barkauskas DS; Stannard K; Sult E; Buonpane R; Takeda K; Teng MWL; Sachsenmeier K; Hay C; Smyth MJ
Oncoimmunology; 2017; 6(5):e1312044. PubMed ID: 28638737
[TBL] [Abstract][Full Text] [Related]
19. The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets.
Allard B; Longhi MS; Robson SC; Stagg J
Immunol Rev; 2017 Mar; 276(1):121-144. PubMed ID: 28258700
[TBL] [Abstract][Full Text] [Related]
20. Gene-expression profiling of different arms of lymphatic vasculature identifies candidates for manipulation of cell traffic.
Iftakhar-E-Khuda I; Fair-Mäkelä R; Kukkonen-Macchi A; Elima K; Karikoski M; Rantakari P; Miyasaka M; Salmi M; Jalkanen S
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10643-8. PubMed ID: 27601677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
